Retour sur lavenir.net
   AGEAS 75.850 € (-1,30 %)     WDP 20.660 € (-1,99 %)     EKOPAK 3.550 € (-1,53 %)     AB INBEV 67.600 € (-1,57 %)     VGP 71.700 € (-1,38 %)     DEME GROUP 180.800 € (-0,88 %)     SHURGARD 23.650 € (+1,28 %)     RETAIL ESTATES 64.600 € (-0,77 %)     MONTEA 63.500 € (-1,55 %)     AEDIFICA 65.600 € (-0,68 %)     ONWARD MEDICAL 2.895 € (+0,17 %)     RECTICEL 12.580 € (-2,93 %)     KINEPOLIS GROUP 49.700 € (-0,10 %)     FAGRON 21.950 € (-1,13 %)     EVS 27.500 € (-1,96 %)     GIMV 46.300 € (-0,86 %)     UMICORE 21.680 € (-2,34 %)     KBC 131.100 € (-1,72 %)     TITAN S.A. 48.300 € (-2,74 %)     ECONOCOM GROUP 1.470 € (-1,34 %)     MELEXIS 66.400 € (+1,45 %)     ARGENX SE 871.400 € (+0,39 %)     PROXIMUS 6.240 € (-5,45 %)     BREDERODE 105.600 € (0,00 %)     IMMOBEL 19.050 € (-1,80 %)     BARCO 7.230 € (-2,36 %)     VAN DE VELDE 29.700 € (-0,67 %)     NYXOAH 1.310 € (-2,82 %)     CFE 10.500 € (-1,41 %)     OPTION 4.220 € (+8,21 %)     ORANGE BELGIUM 22.000 € (-0,45 %)     IBA 15.240 € (-0,13 %)     WERELDHAVE BELGIUM 49.900 € (+0,20 %)     ELIA GROUP 120.700 € (-1,07 %)     CAMPINE 186.000 € (0,00 %)     ONTEX GROUP 2.120 € (-0,93 %)     ACCENTIS 0.026 € (0,00 %)     SYENSQO 77.350 € (-1,09 %)     DECEUNINCK 2.480 € (-0,60 %)     FLUXYS BELGIUM D 22.100 € (0,00 %)     BPOST 1.200 € (-1,64 %)     HOME INVEST BE. 17.840 € (-1,11 %)     TINC 11.020 € (-1,08 %)     SOFINA 246.400 € (-1,36 %)     ASCENCIO 52.500 € (-0,94 %)     JENSEN-GROUP 75.400 € (-0,79 %)     CARE PROPERTY INV. 12.400 € (-1,74 %)     GBL 73.850 € (-1,27 %)     AZELIS GROUP 12.010 € (-1,07 %)     TESSENDERLO 20.500 € (-2,38 %)     XIOR 25.200 € (-0,59 %)     BIOTALYS 1.980 € (+0,81 %)     SOLVAY 25.140 € (-4,41 %)     MATERIALISE 6.750 € (-2,17 %)     UCB 208.100 € (-0,24 %)     KBC ANCORA 94.000 € (-1,26 %)     BEKAERT 37.450 € (-1,83 %)     CENERGY 22.020 € (+1,47 %)     BELYSSE GROUP 0.420 € (-4,55 %)     ACKERMANS V.HAAREN 271.400 € (-0,95 %)  
   LVMH 402.800 € (-2,30 %)     PROSUS 35.850 € (+0,17 %)     L'OREAL 376.050 € (-1,07 %)     VINCI 110.800 € (-1,86 %)     AXA 44.730 € (-0,73 %)     HERMES INTL 1 331.500 € (-3,16 %)     SANOFI 74.050 € (-1,61 %)     DANONE 60.540 € (-1,37 %)     BNP PARIBAS ACT.A 100.740 € (-2,93 %)     SAINT GOBAIN 69.120 € (-1,73 %)     AHOLD DEL 31.600 € (-1,22 %)     AIRBUS 193.380 € (-1,08 %)     AIR LIQUIDE 163.160 € (-1,26 %)     SCHNEIDER ELECTRIC 285.750 € (-0,47 %)     NEXITY 5.255 € (-3,58 %)     ALTAREA 85.300 € (-0,70 %)     WOLTERS KLUWER 68.160 € (-2,74 %)     PERNOD RICARD 59.440 € (-1,13 %)     SHELL PLC 41.315 € (-0,59 %)     UBISOFT ENTERTAIN 5.308 € (-2,61 %)     EUROFINS SCIENT. 76.440 € (-0,57 %)     MYHOTELMATCH 0.125 € (+16,90 %)     AKZO NOBEL 56.080 € (-0,74 %)     CSG 15.432 € (-4,07 %)     ALSTOM 15.280 € (-2,64 %)     VINPAI 2.600 € (-18,75 %)     CEGEDIM 10.500 € (-0,19 %)     MAUREL ET PROM 8.270 € (0,00 %)     EXAIL TECHNOLOGIES 124.500 € (0,00 %)     GECINA 65.500 € (-1,43 %)     SES 4.758 € (-3,25 %)     VIVENDI SE 1.493 € (-2,61 %)     ASM INTERNATIONAL 813.800 € (+2,91 %)     ARCELORMITTAL SA 63.120 € (-3,69 %)     DASSAULT SYSTEMES 20.560 € (-0,10 %)     MICHELIN 33.080 € (-1,37 %)     LEGRAND 135.800 € (-0,37 %)     CHRISTIAN DIOR 369.200 € (-2,17 %)     PHARMING GROUP 0.917 € (-2,28 %)     EUTELSAT COMMUNIC. 1.753 € (-2,99 %)     CAPGEMINI 104.350 € (-2,57 %)     LAKEFRONT BIOTHER. 24.980 € (+0,16 %)     2CRSI 28.360 € (-1,39 %)     HOPIUM 0.004 € (+2,94 %)     EURAZEO 46.420 € (-0,85 %)     HAFFNER ENERGY BSA 0.010 € (-20,83 %)     CREDIT AGRICOLE 18.190 € (-2,23 %)     EXOR NV 68.500 € (-4,06 %)     MAAT PHARMA 1.630 € (-18,50 %)     CORBION 22.660 € (+0,98 %)     ADP 108.300 € (-0,37 %)     ENGIE 24.030 € (-0,91 %)     MERCIALYS 10.480 € (-2,24 %)     BE SEMICONDUCTOR 186.650 € (+2,84 %)     CATERING INTL SCES 21.800 € (+9,55 %)     IMERYS 22.440 € (-0,88 %)     BOUYGUES 43.380 € (-3,28 %)     BRUNEL INTERNAT 7.220 € (-0,55 %)     UMG 14.750 € (+0,07 %)     ACOMO 23.000 € (-1,08 %)  
News Réglementées
08/09/2026 08:45

innoscripta expands business in established Austrian market – order backlog exceeds EUR 1 million

EQS-News: innoscripta SE / Key word(s): Expansion
innoscripta expands business in established Austrian market – order backlog exceeds EUR 1 million

08.09.2026 / 08:45 CET/CEST
The issuer is solely responsible for the content of this announcement.


innoscripta expands business in established Austrian market – order backlog exceeds EUR 1 million

  • Sales team successfully established in Vienna
  • More than 30 customers already acquired; data-driven platform delivers added value in a market established for 24 years

 

Tutzing, 8 September 2026 – innoscripta SE (ISIN: DE000A40QVM8) is further expanding its activities in the Austrian market. A dedicated team established this year focusing on the Austrian R&D tax credit has already acquired more than 30 Austrian companies as customers and built an order backlog of more than EUR 1 million from concrete customer projects. innoscripta has had an office in Vienna since 2021, which until now primarily served to attract talent for the German business.

The Austrian R&D tax credit has been in place since 2002 and provides a 14% tax credit on qualifying R&D expenditure. In 2024, Austrian companies applied for a total funding volume of EUR 1.4 billion. Despite the country’s significantly smaller size, the Austrian market therefore reached a level that was even above the approximately EUR 1.2 billion paid out under Germany’s R&D tax allowance in 2025.

Sebastian Schwertlein, COO, innoscripta SE: “Our rapid market success in Austria is further evidence of the competitiveness of our software-centric approach with the innovative Clusterix platform. We are particularly pleased to have attracted a broad range of new customers across different sectors, including industry and manufacturing, software and IT, logistics, and retail. This demonstrates that our approach works across industries.”

With Austria, innoscripta is continuing its international expansion alongside its market entries in France, the United Kingdom and the United States.

 

About innoscripta

innoscripta SE offers Clusterix, a scalable software platform for the structured organization and management of research and development activities. Companies use Clusterix to efficiently manage innovation projects, digitize internal processes, and make their R&D activities transparent and scalable.

 

Contact

innoscripta SE

Max Hunger

ir@innoscripta.de

 

Press contact

edicto GmbH

Ralf Droz / Svenja Liebig

+49 69 905505 56

innoscripta@edicto.de

 



08.09.2026 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group.
The issuer is solely responsible for the content of this announcement.

The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
View original content: EQS News


Language:English
Company:innoscripta SE
Bahnhofstraße 17
82327 Tutzing
Germany
Phone:+4989255553509
E-mail:info@innoscripta.com
Internet:https://www.innoscripta.com
ISIN:DE000A40QVM8
WKN:A40QVM
Listed:Regulated Unofficial Market in Frankfurt (Scale)
LEI Code:894500BA6B025ZEF0T83
EQS News ID:2395310

 
End of NewsEQS News Service

2395310  08.09.2026 CET/CEST

Source : Webdisclosure.com

© 2026 Tous droits réservés
Cotations différées d'au moins 15 minutes (Paris, Amsterdam, Bruxelles, Lisbonne).
Cotations à la clôture (Francfort, New-York, Londres, Zurich).
Flux de cotations : Euronext (Places Euronext et Cours des Devises).
Bourse : technologie Cote Boursière